The binding of [3H]AF-DX 384 is reduced in the caudate-putamen of subjects with schizophrenia

Life Sciences

Volumn 64, Issue 19, 1999, Pages 1761-1771

  Crook, Jeremy M ^a,b   Dean, Brian ^a,b   Pavey, Geoffrey ^a   Copolov, David ^a  

^a FLOREY INSTITUTE OF NEUROSCIENCE AND MENTAL HEALTH   (Australia)

^b UNIVERSITY OF MELBOURNE   (Australia)

Author keywords

Antipsychotic drug effects; Human brain; Mmuscarinic receptor levels; Schizophrenia

Indexed keywords

N [2 [2 (DIPROPYLAMINOMETHYL) 1 PIPERIDYL]ETHYL] 5,11 DIHYDRO 6 OXO 6H PYRIDO[2,3 B][1,4]BENZODIAZEPINE 11 CARBOXAMIDE; OLANZAPINE; PIRENZEPINE; DRUG DERIVATIVE; MUSCARINIC RECEPTOR BLOCKING AGENT; NEUROLEPTIC AGENT;

ANTICHOLINERGIC EFFECT; ARTICLE; CAUDATE NUCLEUS; CENTRAL NERVOUS SYSTEM FUNCTION; CHOLINERGIC TRANSMISSION; DRUG EFFECT; EXTRAPYRAMIDAL SYMPTOM; HUMAN; HUMAN TISSUE; LIGAND BINDING; NEUROPHYSIOLOGY; PUTAMEN; RECEPTOR BINDING; RECEPTOR DENSITY; SCHIZOPHRENIA; ADULT; AGED; ANIMAL; FEMALE; MALE; METABOLISM; MIDDLE AGED; RAT; SPRAGUE DAWLEY RAT;

ADULT; AGED; ANIMALS; ANTIPSYCHOTIC AGENTS; CAUDATE NUCLEUS; FEMALE; HUMANS; MALE; MIDDLE AGED; MUSCARINIC ANTAGONISTS; PIRENZEPINE; PUTAMEN; RATS; RATS, SPRAGUE-DAWLEY; SCHIZOPHRENIA;

EID: 0033515114     PISSN: 00243205     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0024-3205(99)00114-9     Document Type: Article

References (39)

1. L. Jin-Long and S. Shuang-Ning. Science In China. 36 1510-1517 (1993).
2. U. Grimm, U. Moser, E. Mutschler and G. Lambrecht. Pharmazie. 49 711-726 (1994).
3. R. Tandon, J.E. Shipley, J.G. Greden, N.A. Mann, W.H. Eisner and J.A. Goodson. Schizoph. Res. 4 23-30 (1991).
4. S.H. Zorn, S.B. Jones, K.M. Ward and D.R. Liston. Eur. J. Pharmacol. 269 (R1) (1994).
5. R. Keeper, E. Richelson and A. Nelson. Neuropharmacol. 30 527-529 (1991).
6. R. Tandon, N.A. Mann, W.H. Eisner and N. Coppard. Psychiatry Res. 31 235-241 (1990).
7. V. O'Keane, K. Abel and R.M. Murray. Biol. Psychiatry. 36 582-588 (1994).
8. H.S. Snyder, D. Greenberg, and H.I. Yamumura. J. Psychiat. Res. 11 91-95 (1974).
9. H.S. Snyder, D. Greenberg, and H.I. Yamumura. Arch. Gen. Psychiatry. 31 58-61 (1974).
10. L.A. Baker, L.Y. Cheng, and I.B. Amara. Br. J. Psychiatry. 143 584-590 (1983).
11. B. Dean, J.M. Crook, C. Hill, N. Keks and D.L. Copolov. Molec. Psychiatry, 1 54- 58 (1996).
12. C. Bolden, B. Cusack and E. Richelson. Europ. J. Pharmacol. 192 205-206 (1991).
13. S.H. Zom, S.B. Jones, K.M. Ward and D.R. Liston. Eur. J. Pharmacol. 269 R1-2 (1994).
14. F. Dorje, J. Wess, G. Lambrecht, T. Tacke, E. Mutschler and M.R. Brann. J. Pharmacol. Exp.Ther. 256 727-733 (1991).
15. J.H. Miller, V.A. Gibson and M. Mckinney. J. Pharmacol. Exp. Ther. 259 601-607 (1991)
16. D.G. Spencer, E. Horvath and J. Traber. Brain Res. 380 59-68 (1986).
17. I. Aubert, D. Cecyre, S. Gauthier and R. Quirion. Euro. J. Pharmacol. 217 173- 184 (1992).
18. A.I. Levey, C.A. Kitt, W.F. Simonds, D.L. Price and M.R. Brann. J. Neurosci. 11 3218-3226 (1991).
19. M.R. Brann, N.J. Buckley and T.I. Bonner. FEBS Lett. 230 90-94 (1988).
20. N.J. Buckley, T.I. Bonner and M.R. Brann. J. Neurosci. 8 4646-4652 (1988).
21. W. Billard, H. Binch, G. Crosby and R.D. Mcquade. J. Pharmacol. Exp. Ther. 273 273-279 (1995).
22. T.A. Cawley, T.J. Shickley, M.R. Ruggieri and G. Luthin. J. Pharmacol. Exp. Ther. 267 134-139 (1993).
23. A. Imperato, M.C. Obinu, I. Dazzi and G.L. Gessa. Euro. J. Pharmacol. 251 271-279 (1994).
24. J. Lehmann and S.Z. Langer. Neuroscience. 10 1105-1120 (1983).
25. L.L. Wilkinson (Ed.), MIMS Annual, Tien Wah Press PTY. LTD., Singapore (1989).
26. th Edn, pp. 383-435, Pergmon Press, New York (1990).
27. C. Hill, N. Keks, S. Roberts, K. Opeskin, B. Dean, A. Mackinnon and D. Copolov. Am. J. Psychiatry. 153 533-537 (1996).
28. American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders, 3rd Edn, Revised. The American Psychiatric Press, Washington DC (1987).
29. J.P.G. Vonsattel, H. Aizawa, P. Ge, M. Difiglia, A.C. Mckee, M. Macdonald, J.F. Gusella, G.B. Landwehrmeyer, E.D. Bird, E.P. Richardson, et al. J. Neuropath. Exp. Neurol. 54 42-56 (1995).
30. H. Duvernoy, The Human Brain: Surface Three-dimensional Sectional Anatomy and MRI, Springer-Verlag, Wien (1991).
31. J.B. Acri, B.K. Seidleck, J.M. Witkin, J. Pharmacol. Exp. Ther. 277 198-206 (1996).
32. nd Edn., Academic Press Australia, Sydney (1986).
33. M. Aickin and H. Gensler, Am. J. Public Health. 86 726-728 (1996).
34. J.P. Bennett, S.J. Enna, D.B. Bylund, J.C. Gillin, R.J. Wyatt and S.H. Snyder. Arch. Gen. Psychiatry. 36 927-934 (1979).
35. E.K. Perry and R.H. Perry. P.J. Roberts (ED.), Biochemistry of Dementia, p. 153, John Wiley & Sons, United Kingdom (1980).
36. S. Watanabe, T. Nishikawa, M. Takashima and M. Toru. Life Science. 33 2187-2196 (1983).
37. F. Owen, A.J. Cross, R. Lofthouse and M. Poulter. Acta. Psychiatry Scand. 63 20-27 (1981).
38. C. Bolden, B. Cusack, E. Richelson. J. Pharmacol. Exp. Ther. 260 576-580 (1992).
39. W. Billard, H. Binch, G. Crosby and R.D. Mcquade. J. Pharmacol. Exp. Ther. 273 273-279 (1995).